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Conclusions: In summary, we have characterized a novel target-
ing peptide and showed its specificity as well as its competetive
binding to articular cartilage. Surface functionalisation of PPS
nanoparticles was carried out and showed similar binding at
10% surface functionalisation as the free peptide. After further
optimisation, the functionalized nanoparticles will be labeled and
loaded with small molecule drugs to determine the in vivo tar-
geting of the articular cartilage and their capability of sustained
intra-articular drug release in the cartilage matrix.
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Purpose: Articular cartilage is subjected to complex loading,
which include compressive and shearing forces. These mechan-
ical forces play a major role in the growth, development and
maintenance of the articular cartilage in the body. It is known
that proper stimulation is necessary to promote chondrogenesis.
This means the compressive mechanical stimulation is a very
important factor for the formation of articular cartilage using a
tissue engineering technique. Therefore, it is essential to develop
a mechano-active bioreactor that can deliver the mechanical sig-
nals to adherent cells on polymer scaffolds during the application
of mechanical strain application. The objective of this study is to
evaluate the effect of dynamic compression for the differentiation
of bone marrow stromal cells (BMSCs) within an elastic scaffold
and the formation of cartilaginous tissue.
Methods: The mechano-active scaffolds were fabricated from
a very elastic poly(L-lactide-co-caprolactone) (PLCL) with 85%
porosity and a 300∼500 μm pore size using a gel-pressing
method. The scaffolds were seeded with BMSCs and the contin-
uous compressive stimulation was applied at 0.1Hz for 10 days
in chondrogenic media in order to evaluate the effect of dynamic
compression on differentiation of BMSCs and the secretion of
the chondral extracellular matrix. In addition, the BMSCs seeded
constructs were implanted subcutaneously into nude mice to de-
termine their biocompatibility and cartilaginous tissue formation.
Cell-polymer constructs were characterized by biochemical anal-
ysis, histological studies, and immunofluoresecence staining. For
defining the gene expression for mechanical stimulation, reverse
transcription-polymerase chain reaction was performed.
Results: Mechano-active scaffolds having a complete rubber-like
elasticity were prepared by a gel-pressing method. They could
be easily twisted and bended and showed almost complete (over
97%) recovery at strain applied of up to 500%. In in vitro tests,
the accumulation of extracellular matrix of cell-polymer constructs
showed that chondrogenic differentiation was sustained and en-
hanced significantly by dynamic compressive stimulation. The
GAGs contents of implants stimulated by the dynamic compres-
sive deformation were higher than them without stimulation. His-
tological analysis showed that implants stimulated mechanically
by compression formed mature and well-developed cartilagi-
nous tissue, as evidenced by chondrocytes within lacunae and
an abundant accumulation of sulfated GAGs. From the results,
the periodic application of dynamic compression can encourage
bone marrow stromal cells to differentiation to chongenic lineage
and to maintain their phenotypes. Consequently, it may improve
the quality of cartilaginous tissue formed in vitro and in vivo.
Conclusions: In conclusion, the appropriate periodic application
of dynamic compression can encourage the BMSCs to maintain
their phenotypes, promote differentiation and enhance GAGs
and type II collagen production, as evidenced by the improved
quality of the cartilaginous tissue formed in vitro and in vivo.
Therefore, it is believed that tissue engineering techniques using
mechao-active PLCL scaffolds and dynamic compression would
be very beneficial for cartilaginous tissue formation.
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Purpose: Current methods used to repair localized articular car-
tilage defects include autologous chondrocyte implantation (ACI).
There has been limited success in correlating clinical outcome
with quality of the repair tissue formed. More sophisticated tech-
niques that can assess the molecular features of repair tissue
would aid the evaluation of treatments. Fourier transform infrared
imaging spectroscopy (FT-IRIS) can be used to assess articular
cartilage based on molecular vibrations that arise from its primary
constituents, collagen and proteoglycan (PG). In this study tissue
biopsies obtained one year post-ACI treatments were analyzed
by immunohistochemistry and FT-IRIS to assess the molecular
features of the repair tissue.
Methods: Five male patients (aged 21, 25, 34, 42 and 52 yrs)
were treated with ACI for cartilage defects. Their follow-up treat-
ment included an arthroscopic assessment and biopsy of the
treated area at 12 months post-treatment. Biopsies were sec-
tioned for histological, immunohistochemical (collagen types I
and II) and FT-IRIS analyses and compared to normal human
articular cartilage. Sections on BaF2 windows were analyzed
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for FT-IRIS collecting infrared data at 6.25 or 25μm spatial res-
olution. Absorbance bands were monitored in the 1590-1720
(collagen amide I), 1485-1590 (collagen amide II), 1304-1356
(collagen integrity) and 985-1140 cm-1 (PG sugar) regions. The
quantity and distribution of collagen and PG were assessed via
the integrated area of the amide I region and the ratio of the inte-
grated area of the PG absorbance: amide I collagen absorbance
(PG/AmI), respectively. Collagen integrity was assessed via the
ratio of 1338:AmII and collagen fibril orientation was monitored
with polarized FT-IRIS, via an index of amide I: amide II peak
areas.
Results: Typical FT-IRIS images (Fig 1A) and immunohistochem-
istry and PLM images (Fig 1B) obtained from an ACI biopsy are
shown below. The collagen (Am1) image shows the distribution
of a combination of types I and II collagen. Interestingly, in most
samples, the PG distribution (PG/Am1), although reduced com-
pared to normal cartilage, was similar to the type II collagen
distribution demonstrated by immunohistochemistry. The colla-
gen integrity parameter was higher in all repair tissue samples
than normal articular cartilage, indicative of new collagen forma-
tion. The collagen fibril orientation via FT-IRIS did not display the
typical zonation of normal tissue but the fibrils were more aligned
parallel to the surface (red) in the superficial zone through to
the mid-zone in the repair tissue. There was evidence of fibrils
perpendicular to the surface in the deep zone (blue).
Fig. 1. ACI-treated repair cartilage; 12 months post-surgery. (A) FT-IRIS, and (B)
Immunohistochemical analysis.
Conclusions: Evaluation of the distribution, amount and integrity
of the macromolecular components of cartilage repair tissue is
a critical step in assessing therapeutic and repair protocols. FT-
IRIS allows this information, both qualitative and quantitative, to
be obtained from small quantities of tissue. In this study we have
demonstrated that a typical adult hyaline cartilage phenotype was
not present in these samples, based on collagen type, integrity
and orientation, and PG content. Future studies that focus on
correlation of molecular features with clinical outcome could
enhance optimization of protocols to repair cartilage defects.
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Purpose: Bone tissue regeneration is strictly dependent on ex-
tracellular matrix (ECM) components as well as by inflammatory
and degradative factors that play an important role in the evo-
lution of this process. Hyaluronan (HA), a major component of
ECM in human bone marrow, participates in cell positioning,
proliferation, differentiation at the endosteum following transplan-
tation, cooperates with chemokines in the trafficking of progenitor
cells and regulate the espression of metalloproteinases. In this
study we analysed the interaction between human mesenchymal
stem cells (h-MSCs) and a three-dimensional (3-D) HA-based
scaffold in vitro.
Methods: The expression of CXC chemokines/receptors,
CXCL8 (IL-8)/CXCR1-2, CXCL10 (IP-10)/CXCR3, CXCL12
(SDF-1)/CXCR4 and CXCL13 (BCA-1)/CXCR5 and metallopro-
teinases/inhibitors MMP-1, MMP-3, MMP-13/TIMP-1 were eval-
uated in h-MSCs grown both on plastic or on HA-based scaffold
by real-time PCR, ELISA and immunocytochemical techniques.
Moreover, to assess the direct involvment of HA, the expression
of CD44 and CD54 (two HA receptors), was also analysed.
Results: We found both at mRNA and protein levels that HA-
based scaffold induced the expression of CXCR4, CXCL13
and MMP-3 and down-modulated the expression of CXCL12,
CXCR5, MMP-13 and TIMP-1. Moreover, we demonstrate that
HA-based scaffold induced CD54 expression but not CD44. We
found that these two HA receptors were directly involved in the
modulation of CXCL12, CXCL13 and CXCR5.
Conclusions: This study demonstrates a direct action of a 3-D
HA-based scaffold, widely used for cartilage and bone repair, in
modulating both h-MSCs inflammatory and degradative factors
directly involved in the engraftment of specific cell types in a
damaged area. Our data clearly demonstrate that HA in this
3-D conformation acts as a signaling molecule for h-MSCs, so
suggesting a possible role in tissue engineering of osteoarthritis
patients.
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Purpose: Adult mesenchymal stem cells (MSCs) isolated
from bone marrow (BM) are adherent stromal cells of non-
haematopoietic origin with an intrinsic potential to differentiate
into tissues of mesenchymal lineage including bone and carti-
lage. This study concentrates on a comprehensive profiling of
basal gene expression level of osteo-chondro related genes in
undifferentiated versus differentiated rat adult MSCs and on their
cytokine and growth factor profile.
Methods: Immunofluorescence staining and MACS sorting was
used to characterize the MSCs on the basis of their CD profile.
The chondrogenic differentiation potential of these cells was
confirmed by collagen II staining of their extracellular matrix.
Alizarin red positive staining after osteogenic differentiation was
an indicator for osteogenesis. mRNA expression level of selected
genes normalized to β-actin was analyzed by quantitative RT-
PCR. An antibody array was used to demonstrate a differential
cytokine and growth factor profile of the differentiated versus
undifferentiated MSCs.
Results: The MSC population exhibited a CD45-/low, D7fib+ and
CD49a+ cell surface marker profile. Characterization based on
CD71 and CD106 is being carried out by MACS sorting. In
undifferentiated MSCs high gene expression of Sox-9, TGFβ-3
and Cbfa1 was observed whereas Ihh was comparatively low
and BMP-7 was the lowest expressed gene. Chondrogenesis
- stage specific genes COMP, aggrecan, col2a1 and col10a1
